Freenome is a healthcare company focusing on accurate, accessible, and non-invasive disease screening products. The company was founded in 2014 by Charles Roberts, Gabriel Otte, Riley Ennis, and Michael Otte in South San Francisco, California.The primary goal is to proactively treat cancer and other diseases at their most manageable stages by developing a simple blood test for early-stage cancer detection. The company also provides a platform that designs healthy conditions for individuals based on their cell-free genome.
Operating as a small biotech organization, Freenome functions with only 50 employees and an annual revenue of $3.5 million. The company's mission is to discover biological truth and improve the lives of millions through early detection and early treatment of diseases. With a focus on innovation and reinventing disease management, Freenome aims to be at the forefront of systematized early detection and intervention in the healthcare industry.
